These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32882063)

  • 1. A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.
    Rasmussen SA; Daenzer JMI; Fridovich-Keil JL
    J Inherit Metab Dis; 2021 Jan; 44(1):272-281. PubMed ID: 32882063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.
    Rasmussen SA; Daenzer JMI; MacWilliams JA; Head ST; Williams MB; Geurts AM; Schroeder JP; Weinshenker D; Fridovich-Keil JL
    J Inherit Metab Dis; 2020 May; 43(3):518-528. PubMed ID: 31845342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
    Balakrishnan B; An D; Nguyen V; DeAntonis C; Martini PGV; Lai K
    Mol Ther; 2020 Jan; 28(1):304-312. PubMed ID: 31604675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grip strength in patients with galactosemia and in a galactose-1-phosphate uridylyltransferase (GALT)-null rat model.
    Druss JJ; Rudd Zhong Manis J; Potter NL; Fridovich-Keil JL
    J Inherit Metab Dis; 2023 Nov; 46(6):1131-1138. PubMed ID: 37776278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation.
    Daenzer JM; Jumbo-Lucioni PP; Hopson ML; Garza KR; Ryan EL; Fridovich-Keil JL
    Dis Model Mech; 2016 Nov; 9(11):1375-1382. PubMed ID: 27562100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.
    Tang M; Siddiqi A; Witt B; Yuzyuk T; Johnson B; Fraser N; Chen W; Rascon R; Yin X; Goli H; Bodamer OA; Lai K
    Eur J Hum Genet; 2014 Oct; 22(10):1172-9. PubMed ID: 24549051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.
    Jumbo-Lucioni PP; Hopson ML; Hang D; Liang Y; Jones DP; Fridovich-Keil JL
    Dis Model Mech; 2013 Jan; 6(1):84-94. PubMed ID: 22773758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK.
    Oh SL; Cheng LY; J Zhou JF; Henke W; Hagen T
    J Inherit Metab Dis; 2020 May; 43(3):529-539. PubMed ID: 31774565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary galactosemia.
    Demirbas D; Coelho AI; Rubio-Gozalbo ME; Berry GT
    Metabolism; 2018 Jun; 83():188-196. PubMed ID: 29409891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia.
    Jumbo-Lucioni PP; Ryan EL; Hopson ML; Bishop HM; Weitner T; Tovmasyan A; Spasojevic I; Batinic-Haberle I; Liang Y; Jones DP; Fridovich-Keil JL
    Antioxid Redox Signal; 2014 May; 20(15):2361-71. PubMed ID: 23758052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosemia: when is it a newborn screening emergency?
    Berry GT
    Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase.
    Riehman K; Crews C; Fridovich-Keil JL
    J Biol Chem; 2001 Apr; 276(14):10634-40. PubMed ID: 11152465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Mutation in GALT Gene in Galactosemia Patient with Group B Streptococcus Meningitis and Acute Liver Failure.
    Grama A; Blaga L; Nicolescu A; Deleanu C; Militaru M; Căinap SS; Pop I; Tita G; Sîrbe C; Fufezan O; Vințan MA; Vulturar R; Pop TL
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and functional studies reveal a novel noncoding variant in GALT associated with a false positive newborn screening result for galactosemia.
    Liu Y; Sidhu A; Bean LH; Conway RL; Fridovich-Keil JL
    Clin Chim Acta; 2015 Jun; 446():171-4. PubMed ID: 25920691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet.
    Ning C; Reynolds R; Chen J; Yager C; Berry GT; Leslie N; Segal S
    Mol Genet Metab; 2001 Apr; 72(4):306-15. PubMed ID: 11286504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient.
    Schulpis KH; Thodi G; Chatzidaki M; Iakovou K; Molou E; Dotsikas Y; Loukas YL
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1119-1120. PubMed ID: 28902631
    [No Abstract]   [Full Text] [Related]  

  • 17. A multinational study of acute and long-term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT.
    Katler QS; Stepien KM; Paull N; Patel S; Adams M; Balci MC; Berry GT; Bosch AM; DeLaO A; Demirbas D; Edman J; Ficicioglu C; Goff M; Hacker S; Knerr I; Lancaster K; Li H; Mendelsohn BA; Nichols B; de Rezende Pinto WBV; Rocha JC; Rubio-Gozalbo ME; Saad-Naguib M; Scholl-Buergi S; Searcy S; de Souza PVS; Wittenauer A; Fridovich-Keil JL
    J Inherit Metab Dis; 2022 Nov; 45(6):1106-1117. PubMed ID: 36093991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hand fine motor control in classic galactosemia.
    MacWilliams J; Patel S; Carlock G; Vest S; Potter NL; Fridovich-Keil JL
    J Inherit Metab Dis; 2021 Jul; 44(4):871-878. PubMed ID: 33720431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of classic galactosemia: lessons from the GalNet registry.
    Rubio-Gozalbo ME; Haskovic M; Bosch AM; Burnyte B; Coelho AI; Cassiman D; Couce ML; Dawson C; Demirbas D; Derks T; Eyskens F; Forga MT; Grunewald S; Häberle J; Hochuli M; Hubert A; Huidekoper HH; Janeiro P; Kotzka J; Knerr I; Labrune P; Landau YE; Langendonk JG; Möslinger D; Müller-Wieland D; Murphy E; Õunap K; Ramadza D; Rivera IA; Scholl-Buergi S; Stepien KM; Thijs A; Tran C; Vara R; Visser G; Vos R; de Vries M; Waisbren SE; Welsink-Karssies MM; Wortmann SB; Gautschi M; Treacy EP; Berry GT
    Orphanet J Rare Dis; 2019 Apr; 14(1):86. PubMed ID: 31029175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach.
    Freer DE; Ficicioglu C; Finegold D
    Clin Chem; 2010 Mar; 56(3):437-44. PubMed ID: 20075179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.